Large-scale convalescent blood and plasma transfusion therapy for ebola virus disease

Journal of Infectious Diseases

Volumn 211, Issue 8, 2015, Pages 1208-1210

  Colebunders, Robert L ^a,b   Cannon, Robert O ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

blood transfusions; Ebola virus disease; plasma transfusion; treatment

Indexed keywords

BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; EBOLA HEMORRHAGIC FEVER; FATALITY; HEALTH CARE DELIVERY; HEALTH PROGRAM; HELP SEEKING BEHAVIOR; HOSPITALIZATION; HUMAN; INFECTION RATE; NOTE; PATIENT CARE; PLASMA TRANSFUSION; PRIORITY JOURNAL; THERAPY EFFECT; VIRUS TRANSMISSION; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY;

EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84926636978     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv043     Document Type: Note

References (23)

1. World Health Organization. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. Interim guidance for national health authorities and blood transfusion services. Geneva: World Health Organization, 2015. http://www.euro.who.int/data/assets/pdf-file/0011/268787/. Accessed 2 February 2015.
2. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2015; 211:80-90.
3. Gutfrainhd A, Meyers LA. Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia. J Infect Dis 2015; 211:1262-7.
4. Meltzer MI, Atkins CY, Santibanez S, et al. Estimating the future number of cases in the Ebola epidemic-Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ 2014; 63(suppl 3):1-14.
5. Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 1999; 179(suppl 1): S18-23.
6. Burnouf T, Seghatchian J. Ebola virus convalescent blood products: Where we are now and where we may need to go. Transfus Apher Sci 2014; 51:120-5.
7. Butler D. Ebola raises profile of blood-based therapy. Nature 2015; 517:9-10.
8. Cohen J, Kupferschmidt K. A dose of reality. Science 2014; 346:908-11.
9. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371:2092-100.
10. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015; 372:40-7.
11. Dallatomasinas S, Crestani R, Squire JS, et al. Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health 2015; doi:10.1111/tmi.12454.
12. Ansumana R, Jacobsen KH, Idris M, et al. Ebola in Freetown Area, Sierra Leone-a case study of 581 patients. N Engl J Med 2014; 372:587-8.
13. Cox E, Borio L, Temple R. Evaluating Ebola therapies-the case for RCTs. N Engl J Med 2014; 371:2350-1.
14. World Health Organization. Ebola situation. Geneva: World Health Organization, 2015. http://www.who.int/csr/disease/ebola/situation-reports/. Accessed 2 February 2015.
15. Drake JM, Kaul RB, Alexander LW, et al. Ebola cases and health system demand in Liberia. PLoS Biol 2015; 13:e1002056.
16. Epstein JM, Sauer LM, Chelen J, et al. Infectious disease: mobilizing Ebola survivors to curb the epidemic. Nature 2014; 516:323-5.
17. Bannister-Tyrrell M, Gryseels C, Delamou A, et al. Blood as medicine: social meanings of blood and the success of Ebola trials. Lancet 2015; doi:10.1016/S0140-6736(14)62392-8.
18. Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179(suppl 1):S13-4.
19. De Roo A, Ado B, Rose B, Guimard Y, Fonck K, Colebunders R. Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health 1998; 3:883-5.
20. Brett-Major DM, Jacob ST, Jacquerioz FA, et al. Being ready to treat Ebola virus disease patients. Am J Trop Med Hyg 2014; pii:14-0746.
21. Cohen J. Saving lives without new drugs. Science 2014; 346:911.
22. Roberts I, Perner A. Ebola virus disease: clinical care and patient-centred research. Lancet 2014; 384:2001-2.
23. De Clerck E. Ebola virus (EBOV) infection: therapeutic strategies. Biochem Pharmacol 2015; 93:1-10.